ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 258 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $91,000 | +46.8% | 1,450 | -1.4% | 0.01% | +66.7% |
| Q1 2020 | $62,000 | -7.5% | 1,470 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $67,000 | 0.0% | 1,470 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $67,000 | -2.9% | 1,470 | +25.6% | 0.00% | 0.0% |
| Q2 2019 | $69,000 | +32.7% | 1,170 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $52,000 | -75.1% | 1,170 | -78.2% | 0.00% | -71.4% |
| Q4 2018 | $209,000 | -18.4% | 5,370 | -3.6% | 0.01% | 0.0% |
| Q3 2018 | $256,000 | +3.2% | 5,570 | -1.9% | 0.01% | 0.0% |
| Q2 2018 | $248,000 | – | 5,680 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |